Amor and colleagues identified the urokinase-type plasminogen activator receptor (uPAR) as a SnC-surface marker and showed that uPAR-specific CAR T cells can efficiently eliminate lung cancer cells induced into senescence in response to combined therapeutic treatment (i.e. MEK plus CDK4/6 inhibitors). Here, PLAUR is linked to lung carcinoma.